Investing in emerging companies and businesses to take advantage of the latest prospects in Medical Cannabis, CBD and Hemp.

Canna Capital works in the heart of the medical cannabis market to identify and pursue investment opportunities. By investing in this promising emerging market, we are taking advantage of strong economic growth prospects in legal medical marijuana stocks.

Learn More

CANC

Medical Cannabis UK: Our Investment Strategy

Canna Capital seeks to discover, vet, and invest in opportunities in the burgeoning medical cannabis market globally with a specific focus on the UK where the board has exceptional experience. The company will target some of the most untapped yet valuable assets in medical cannabis including R&D, patents and other Intellectual Properties which can add real value to the company’s portfolio.

The production of medical cannabis in the U.K. has risen by more than 500% in the past five years, and the drug was legalised for medical use in 2018. As it is in many parts of the world, the medicinal cannabis market is growing, and increasing public acceptance and relaxed government regulations make this market ripe for high-yield, long-term investment success.

Medical marijuana is a safe and effective medicine and has been involved in a number of scientific, peer-reviewed studies as well as ongoing clinical trials. Rx medical cannabis has been successfully used to treat a variety of conditions, including Alzheimer’s disease, ALS, HIV/AIDS, cancer, Crohn’s disease, epilepsy, seizures, glaucoma, multiple sclerosis, muscle spasms, severe and chronic pain, and severe nausea.

Contact Canna Capital today to learn how we are identifying lucrative investment prospects in this burgeoning market.